Ira Shafran MD AGAF
Inflammatory Bowel Disease
Director Shafran Gastroenterology Research
Join to View Full Profile
1004 Temple GrvWinter Park, FL 32789
Phone+1 407-310-5520
Fax+1 407-539-2242
Dr. Shafran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a clinical researcher devoted to the study of inflammatory bowel disease.
Our website can be seen at www.shafran.net
Please look at our site to visit our wonderful practice and our experience in pivotal clinical trials to help our IBD patients.
Education & Training
Ohio State University HospitalFellowship, Gastroenterology, 1977 - 1979- Ohio State University HospitalResidency, Internal Medicine, 1975 - 1977
- Ohio State University HospitalInternship, Internal Medicine, 1974 - 1975
- Ohio State University College of MedicineClass of 1974
Certifications & Licensure
FL State Medical License 1979 - 2020
AGAAGAF
Awards, Honors, & Recognition
- Top Doctors: Florida Castle Connolly, 2000-2014
- Top MD Consumers Checkbook
Clinical Trials
- Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy Start of enrollment: 2010 Jan 01
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 2 citationsCytokine expression in subjects withssp.positive blood cultures and a meta-analysis of cytokine expression in Crohn's disease.J Todd Kuenstner, Qiang Xu, Tim J Bull, Antonio C G Foddai, Irene R Grant
Frontiers in Cellular and Infection Microbiology. 2024-01-01 - 57 citationsEtrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, ran...Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez
The Lancet. Gastroenterology & Hepatology. 2021-11-17 - 42 citationsEtrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3...Severine Vermeire, Peter L. Lakatos, Timothy Ritter, Stephen B. Hanauer, Brian Bressler
The Lancet. Gastroenterology & Hepatology. 2021-11-16
Journal Articles
- Utility of Video Capsule Endoscopy for Longitudinal Monitoring of Crohn’s Disease Activity in the Small Bowel: A Prospective StudyGil Y Melmed, Marla C Dubinsky, David T Rubin, Shabana F Pasha, Atsushi Sakuraba, Felix Tiongco, Ira Shafran, Jonathan A Leighton, Gastrointestinal Endoscopy
Press Mentions
Diverticulitis Causes and Risk FactorsSeptember 30th, 2022
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
